Frank Hoentjen1,2, Michiel E de Jong3, Iris D Nagtegaal4, Shoko Vos4, Rachel S van der Post4, Yasmijn van Herwaarden1, Lauranne A A P Derikx1. 1. Inflammatory Bowel Disease Centre, Department of Gastroenterology and Hepatology, Radboud University Medical Centre, P.O. Box 9101, code 455, 6500 HB, Nijmegen, The Netherlands. 2. Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Canada. 3. Inflammatory Bowel Disease Centre, Department of Gastroenterology and Hepatology, Radboud University Medical Centre, P.O. Box 9101, code 455, 6500 HB, Nijmegen, The Netherlands. Michiel.E.deJong@radboudumc.nl. 4. Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Abstract
BACKGROUND: The impact of serrated polyps on the advanced colorectal neoplasia (CRN) risk in inflammatory bowel disease (IBD) patients is unknown. Serrated polyps are histologically categorized as hyperplastic polyps (HPs), sessile serrated lesions (SSLs), and traditional serrated adenomas (TSAs). AIMS: We aimed (1) to characterize the serrated polyps in IBD patients, (2) to identify factors associated with the presence of serrated polyps in IBD, and (3) to assess the CRN risk in IBD patients with serrated polyps. METHODS: We established a retrospective cohort of IBD patients with and without colonic serrated polyps. Cox-regression analysis with time-dependent variables was used to compare advanced CRN risk in IBD patients with and without serrated polyps. RESULTS: Of the 621 enrolled IBD patients, 198 had a serrated polyp (92 HPs, 88 SSLs without dysplasia, 13 SSLs with dysplasia, and 5 TSAs). Independent factors associated with serrated polyps were ulcerative colitis (UC) (odds ratio (OR) 1.77, 95% confidence interval (CI) 1.19-2.62, p = 0.005), male gender (OR 1.63, 95% CI 1.11-2.40, p = 0.013), and older age (per year increase, OR 1.06, 95%CI 1.05-1.08, p < 0.001). TSAs and SSLs with dysplasia were risk factors for subsequent advanced CRN (HR 13.51, 95% CI 3.11-58.68, p < 0.001), while HPs (HR 1.98, 95% CI 0.46-8.60, p = 0.36) and SSLs without dysplasia (HR 0.87, 95% CI 0.11-6.88, p-0.89) did not impact the subsequent advanced CRN risk. CONCLUSIONS: UC, male gender and older age were associated with the presence of serrated polyps. The majority of serrated polyps (91%) were HPs and SSL without dysplasia and did not affect the CRC risk. However TSAs and SSLs with dysplasia, representing a small subgroup of serrated polyps (9%), were associated with subsequent advanced CRN.
BACKGROUND: The impact of serrated polyps on the advanced colorectal neoplasia (CRN) risk in inflammatory bowel disease (IBD) patients is unknown. Serrated polyps are histologically categorized as hyperplastic polyps (HPs), sessile serrated lesions (SSLs), and traditional serrated adenomas (TSAs). AIMS: We aimed (1) to characterize the serrated polyps in IBD patients, (2) to identify factors associated with the presence of serrated polyps in IBD, and (3) to assess the CRN risk in IBD patients with serrated polyps. METHODS: We established a retrospective cohort of IBD patients with and without colonic serrated polyps. Cox-regression analysis with time-dependent variables was used to compare advanced CRN risk in IBD patients with and without serrated polyps. RESULTS: Of the 621 enrolled IBD patients, 198 had a serrated polyp (92 HPs, 88 SSLs without dysplasia, 13 SSLs with dysplasia, and 5 TSAs). Independent factors associated with serrated polyps were ulcerative colitis (UC) (odds ratio (OR) 1.77, 95% confidence interval (CI) 1.19-2.62, p = 0.005), male gender (OR 1.63, 95% CI 1.11-2.40, p = 0.013), and older age (per year increase, OR 1.06, 95%CI 1.05-1.08, p < 0.001). TSAs and SSLs with dysplasia were risk factors for subsequent advanced CRN (HR 13.51, 95% CI 3.11-58.68, p < 0.001), while HPs (HR 1.98, 95% CI 0.46-8.60, p = 0.36) and SSLs without dysplasia (HR 0.87, 95% CI 0.11-6.88, p-0.89) did not impact the subsequent advanced CRN risk. CONCLUSIONS: UC, male gender and older age were associated with the presence of serrated polyps. The majority of serrated polyps (91%) were HPs and SSL without dysplasia and did not affect the CRC risk. However TSAs and SSLs with dysplasia, representing a small subgroup of serrated polyps (9%), were associated with subsequent advanced CRN.
Authors: Stuart R Cairns; John H Scholefield; Robert J Steele; Malcolm G Dunlop; Huw J W Thomas; Gareth D Evans; Jayne A Eaden; Matthew D Rutter; Wendy P Atkin; Brian P Saunders; Anneke Lucassen; Paul Jenkins; Peter D Fairclough; Christopher R J Woodhouse Journal: Gut Date: 2010-05 Impact factor: 23.059
Authors: Francis A Farraye; Robert D Odze; Jayne Eaden; Steven H Itzkowitz; Robert P McCabe; Themistocles Dassopoulos; James D Lewis; Thomas A Ullman; Tom James; Robin McLeod; Lawrence J Burgart; John Allen; Joel V Brill Journal: Gastroenterology Date: 2010-02 Impact factor: 22.682
Authors: Jeanne Shen; Joanna A Gibson; Stephanie Schulte; Hema Khurana; Francis A Farraye; Jonathan Levine; Robert Burakoff; Sandra Cerda; Taha Qazi; Matthew Hamilton; Amitabh Srivastava; Robert D Odze Journal: Hum Pathol Date: 2015-07-08 Impact factor: 3.466
Authors: Huaibin M Ko; Noam Harpaz; Russell B McBride; Miao Cui; Fei Ye; David Zhang; Thomas A Ullman; Alexandros D Polydorides Journal: Mod Pathol Date: 2015-09-25 Impact factor: 7.842
Authors: Rune Erichsen; John A Baron; Stephen J Hamilton-Dutoit; Dale C Snover; Emina Emilia Torlakovic; Lars Pedersen; Trine Frøslev; Mogens Vyberg; Stanley R Hamilton; Henrik Toft Sørensen Journal: Gastroenterology Date: 2015-12-08 Impact factor: 22.682
Authors: Michiel E De Jong; Sanne B Van Tilburg; Loes H C Nissen; Wietske Kievit; Iris D Nagtegaal; Carmen S Horjus; Tessa E H Römkens; Joost P H Drenth; Frank Hoentjen; Lauranne A A P Derikx Journal: J Crohns Colitis Date: 2019-12-10 Impact factor: 9.071